HDFC Life Insurance sheds 3% post Q2 results; brokerages remain upbeat
Systematix and Elara rate stocks including HDFC Life.
· Business Standard Mkts
Analysts at Systematix Institutional Research and Elara Securities retained a 'Buy' rating on HDFC Life stock, highlighting that Value of New Business in Q2 came in ahead of Q2 estimates.
The analysis
Earnings versus expectations is what actually re-rates a stock; the surprise matters more than the absolute number.
Market context
- Brokerage calls from Systematix and Elara, with ratings on the stocks named. The stocks: HDFC Life.
- Over three months: HDFC Life -3.8% against Insurance -13.4% (9.6 points ahead).
- At least 25% below the 52-week high: HDFC Life (33%).
| Company | Price | Day | 1M | 3M | From 52-wk high | Volume vs 20-day | Market cap |
|---|---|---|---|---|---|---|---|
| HDFC LifeHDFCLIFE · Insurance | ₹524.90 | +1.5% | +0.7% | -3.8% | -33.4% | 1.0× | — |
Insurance
1M -5.4% · 3M -13.4%
HDFC Life
Prices as of 30 Oct 2026, 16:10 IST. Sector moves are the average of the stocks we track in each sector.
In this story
HDFCLIFEInsurance